Stock Events

Stock Events

Lilly(Eli) & 

C$15.00
12764
+C$0.14+0.94% 18:11 Today

Statistics

Day High
15.14
Day Low
15
52W High
15.14
52W Low
9.09
Volume
300
Avg. Volume
314
Mkt Cap
13.36B
P/E Ratio
0.39
Dividend Yield
0.48%
Dividend
0.07

Upcoming

Dividends

0.48%Dividend Yield
Sep 2026
C$0.02
Jun 2026
C$0.02
Mar 2026
C$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Feb 10Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
7.96
10.54
13.11
15.69
Expected EPS
15.68807125281
Actual EPS
N/A

Financials

31.56%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
90.46BRevenue
28.55BNet Income

Analyst Ratings

$1,576.86Average Price Target
The highest estimate is ⁦1,800.71⁩.
From 17 ratings within the last 6 months. This is not an investment recommendation.
Buy
94%
Hold
0%
Sell
6%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZLLY.NEO. It's not an investment recommendation.
NVIDIA
4889
NVDA
Microsoft
4305
MSFT
Amazon
3231
AMZN
Apple
3159
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer competes directly with Eli Lilly in various therapeutic areas, including oncology, immunology, and cardiovascular diseases.
Merck
MRK
Mkt Cap368.89B
Merck is a key competitor in the pharmaceutical industry, particularly in the fields of oncology and diabetes, where both companies have significant investments.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson competes with Eli Lilly through its pharmaceutical segment, particularly in immunology and oncology.
Novartis
NVS
Mkt Cap303.67B
Novartis competes in similar therapeutic areas as Eli Lilly, including neuroscience and oncology, with a strong focus on research and development.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes with Eli Lilly in the immunology market, particularly in treatments for autoimmune diseases.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a competitor in the oncology and cardiovascular markets, areas where Eli Lilly also operates.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes with Eli Lilly in several areas, including oncology, cardiovascular, and respiratory diseases.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes with Eli Lilly in areas such as immunology and respiratory diseases.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with Eli Lilly in diabetes care and vaccines, among other areas.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with Eli Lilly in oncology and neuroscience, with a strong emphasis on biopharmaceuticals.

About

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Show More
CEO
David A. Ricks
Employees
50000
Country
United States
ISIN
CA2869111021
WKN
000A41U1D

Listings

BK
TH
LLY80.BK
MU
DE
LLY0.MU
STU
DE
LLY.STU
MI
IT
1LLY.MI

0 Comments

Share your thoughts

FAQs

What is Lilly(Eli) & stock price today?▼
The current price of ZLLY.NEO is C$15.00 CAD — it has increased by +0.94% in the past 24 hours. Watch Lilly(Eli) & stock price performance more closely on the chart.
What is Lilly(Eli) & stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NEO Exchange exchange Lilly(Eli) & stocks are traded under the ticker ZLLY.NEO.
What is Lilly(Eli) & market cap?▼
Today Lilly(Eli) & has the market capitalization of 13.36B
When is the next Lilly(Eli) & earnings date?▼
Lilly(Eli) & is going to release the next earnings report on February 10, 2027.
What were Lilly(Eli) & earnings last quarter?▼
ZLLY.NEO earnings for the last quarter are 10.46 CAD per share, whereas the estimation was 7.99 CAD resulting in a +30.99% surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is Lilly(Eli) & revenue for the last year?▼
Lilly(Eli) & revenue for the last year amounts to 90.46B CAD.
What is Lilly(Eli) & net income for the last year?▼
ZLLY.NEO net income for the last year is 28.55B CAD.
Does Lilly(Eli) & pay dividends?▼
Yes, ZLLY.NEO dividends are paid quarterly. The last dividend per share was 0.02 . As of today, Dividend Yield (FWD)% is 0.48%.
How many employees does Lilly(Eli) & have?▼
As of November 4, 2026, the company has 50,000 employees.
In which sector is Lilly(Eli) & located?▼
Lilly(Eli) & operates in the Health & Wellness sector.
When did Lilly(Eli) & complete a stock split?▼
Lilly(Eli) & has not had any recent stock splits.
Where is Lilly(Eli) & headquartered?▼
Lilly(Eli) & is headquartered in INDIANAPOLIS, United States.